References
1
MacLennan WJ, Wilson J, Rattenhuber V, et al. Hydroxyethylrutosides in elderly patients with chronic venous insufficiency: its efficacy and tolerability.
Gerontology
1994;40:45-52.
2
Pulvertaft TB. Paroven in the treatment of chronic venous insufficiency.
Practitioner. 1979;223:838-841.
3
Pulvertaft TB. General practice treatment of symptoms of venous insufficiency with oxerutins. Results of a 660 patient multicentre study in the UK.
Vasa.
1983;12:373-376.
4
Rehn D, Brunnauer H, Diebschlag W, et al. Investigation of the therapeutic equivalence of different galenical preparations of O-(beta-hydroxyethyl)-rutosides following multiple dose peroral administration.
Arzneimittelforschung.
1996;46:488-492.
5
Rehn D, Unkauf M, Klein P, et al. Comparative clinical efficacy and tolerability of oxerutins and horse chestnut extract in patients with chronic venous insufficiency.
Arzneimittelforschung.
1996;46:483-487.
6
Rehn D, Golden G, Nocker W, et al. Comparison between the efficacy and tolerability of oxerutins and troxerutin in the treatment of patients with chronic venous insufficiency.
Arzneimittelforschung.
1993;43:1060-1063.
7
Unkauf M, Rehn D, Klinger J, et al. Investigation of the efficacy of oxerutins compared to placebo in patients with chronic venous insufficiency treated with compression stockings.
Arzneimittelforschung.
1996;46:478-482.
8
Boisseau MR, Taccoen A, Garreau C, et al. Fibrinolysis and hemorheology in chronic venous insufficiency: a double blind study of troxerutin efficiency.
J Cardiovasc Surg (Torino).
1995;36:369-374.
9
Balmer A, Limoni C. A double blind placebo-controlled clinical trial of Venoruton on the symptoms and signs of chronic venous insufficiency. The importance of patient selection [in German].
Vasa.
1980;9:76-82.
10
Bergqvist D, Hallbk T, Lindblad B, et al. A double-blind trial of O-(beta-Hydroxyethyl)-Rutoside in patients with chronic venous insufficiency.
Vasa.
1981;10:253-260.
11
Anderson JH, Geraghty JG, Wilson YT, et al. Paroven and graduated compression hosiery for superficial venous insufficiency.
Phlebology. 1990;5:271-276.
12
van Cauwenberge H. Double blind study of the efficacy of O(beta-hydroxyethyl)-rutosides in the treatment of venous conditions [in French].
Med Hyg (Geneve).
1978;36:4175-4177.
13
de Jongste AB, Jonker JJC, Huisman MV, et al. A double blind three center clinical trial on the short-term efficacy of 0-(beta-hydroxyethyl)-rutosides in patients with post-thrombotic syndrome.
Thromb Haemost.
1989;62:826-829.
14
Prerovsky I, Roztocil K, Hlavova A, et al. The effect of hydroxyethylrutosides after acute and chronic oral administration in patients with venous diseases. A double-blind study.
Angiologica. 1972;9:408-414.
15
Cappelli R, Pecchi S, Oberhausser V, et al. Efficacy of O-(beta-hydroxyethy)-rutosides at high dosages in counteracting the unwanted activity of oral contraceptives on venous function.
Int J Clin Pharmacol Res. 1987;7:291-299.
16
Stegmann W, Hubner K, Deichmann B, et al. The efficacy of O-(beta-hydroxyethyl)-rutosides in the treatment of venous leg ulcers [in French].
Phlebologie. 1987;40:149-156.
17
Wadworth AN, Faulds D. Hydroxyethylrutosides. A review of its pharmacology, and therapeutic efficacy in venous insufficiency and related disorders.
Drugs.
1992;44:1013-1032.
18
Wright DD, Franks PJ, Blair SD, et al. Oxerutins in the prevention of recurrence in chronic venous ulceration: randomized controlled trial.
Br J Surg (England).
1991;78:1269-1270.
19
Sohn C, Jahnichen C, Bastert G. Effectiveness of beta-hydroxyethylrutoside in patients with varicose veins in pregnancy [in German].
Zentralbl Gynakol.
1995;117:190-197.
20
Bergstein NAM. Clinical study on the efficacy of O-(beta-Hydroxyethyl)Rutoside (HR) in varicosis of pregnancy.
J Int Med Res.
1975;3:189-193.
21
Wijayanegara H, Mose JC, Achmad L, et al. A clinical trial of hydroxyethylrutosides in the treatment of hemorrhoids of pregnancy.
J Int Med Res.
1992;20:54-60.
22
Wadworth AN, Faulds D. Hydroxyethylrutosides. A review of its pharmacology, and therapeutic efficacy in venous insufficiency and related disorders.
Drugs. 1992;44:1013-1032.
23
Taylor HM, Rose KE, Twycross RG. A double-blind clinical trial of hydroxyethylrutosides in obstructive arm lymphoedema.
Phlebologie.
1993;(suppl 1):22-28.
24
Mortimer PS, Badger C, Clarke I, et al. A double-blind, randomized, parallel-group, placebo-controlled trial of O-(beta-Hydroxyethyl)-Rutosides in chronic arm oedema resulting from breast cancer treatment.
Phlebologie.
1995;10:51-55.
25
Piller NB, Morgan RG, Casley-Smith JR. A double-blind, cross-over trial of O-(beta-hydroxyethyl)-rutosides (benzo-pyrones) in the treatment of lymphoedema of the arms and legs.
Br J Plast Surg.
1988;41:20-27.
26
Fassina A, Rubinacci A. Post-traumatic oedemas. A controlled study into the activity of hydroxyethylrutoside [translated from Italian].
Gazz Med Ital Arch Sci.
1987;146:103-109.
27
Moser M, Ranacher G, Wilmot TJ, et al. A double-blind clinical trial of hydroxyethylrutosides in Meniere's disease.
J Laryngol Otol.
1984;98:265-272.
28
Wadworth AN, Faulds D. Hydroxyethylrutosides. A review of its pharmacology, and therapeutic efficacy in venous insufficiency and related disorders.
Drugs.
1992;44:1013-1032.
29
Pulvertaft TB. General practice treatment of symptoms of venous insufficiency with oxerutins. Results of a 660 patient multicentre study in the UK.
Vasa.
1983;12:373-376.
30
Unkauf M, Rehn D, Klinger J, et al. Investigation of the efficacy of oxerutins compared to placebo in patients with chronic venous insufficiency treated with compression stockings.
Arzneimittelforschung.
1996;46:478-482.
31
MacLennan WJ, Wilson J, Rattenhuber V, et al. Hydroxyethylrutosides in elderly patients with chronic venous insufficiency: its efficacy and tolerability.
Gerontology
1994;40:45-52.
32
Rehn D, Brunnauer H, Diebschlag W, et al. Investigation of the therapeutic equivalence of different galenical preparations of O-(beta-hydroxyethyl)-rutosides following multiple dose peroral administration.
Arzneimittelforschung.
1996;46:488-492.
33
Rehn D, Unkauf M, Klein P, et al. Comparative clinical efficacy and tolerability of oxerutins and horse chestnut extract in patients with chronic venous insufficiency.
Arzneimittelforschung.
1996;46:483-487.
34
Balmer A, Limoni C. A double blind placebo-controlled clinical trial of Venoruton on the symptoms and signs of chronic venous insufficiency. The importance of patient selection [in German].
Vasa.
1980;9:76-82.
35
Bergqvist D, Hallbook T, Lindblad B, et al. A double-blind trial of O-(beta-Hydroxyethyl)-Rutoside in patients with chronic venous insufficiency.
Vasa.
1981;10:253-260.
36
Anderson JH, Geraghty JG, Wilson YT, et al. Paroven and graduated compression hosiery for superficial venous insufficiency.
Phlebology. 1990;5:271-276.
37
van Cauwenberge H. Double blind study of the efficacy of O(beta-hydroxyethyl)-rutosides in the treatment of venous conditions [in French].
Med Hyg (Geneve).
1978;36:4175-4177.
38
de Jongste AB, Jonker JJC, Huisman MV, et al. A double blind three center clinical trial on the short-term efficacy of 0-(beta-hydroxyethyl)-rutosides in patients with post-thrombotic syndrome.
Thromb Haemost.
1989;62:826-829.
39
Prerovsky I, Roztocil K, Hlavova A, et al. The effect of hydroxyethylrutosides after acute and chronic oral administration in patients with venous diseases. A double-blind study.
Angiologica. 1972;9:408-414.
40
Cappelli R, Pecchi S, Oberhausser V, et al. Efficacy of O-(beta-hydroxyethy)-rutosides at high dosages in counteracting the unwanted activity of oral contraceptives on venous function.
Int J Clin Pharmacol Res. 1987;7:291-299.
41
Boisseau MR, Taccoen A, Garreau C, et al. Fibrinolysis and hemorheology in chronic venous insufficiency: a double blind study of troxerutin efficiency.
J Cardiovasc Surg (Torino).
1995;36:369-374.
42
Rehn D, Golden G, Nocker W, et al. Comparison between the efficacy and tolerability of oxerutins and troxerutin in the treatment of patients with chronic venous insufficiency.
Arzneimittelforschung.
1993;43:1060-1063.
43
Bergstein NAM. Clinical study on the efficacy of O-(beta-Hydroxyethyl)Rutoside (HR) in varicosis of pregnancy.
J Int Med Res.
1975;3:189-193.
44
Sohn C, Jahnichen C, Bastert G. Effectiveness of beta-hydroxyethylrutoside in patients with varicose veins in pregnancy [in German].
Zentralbl Gynakol.
1995;117:190-197.
45
Stegmann W, Hubner K, Deichmann B, et al. The efficacy of O-(beta-hydroxyethyl)-rutosides in the treatment of venous leg ulcers [in French].
Phlebologie. 1987;40:149-156.
46
Wadworth AN, Faulds D. Hydroxyethylrutosides. A review of its pharmacology, and therapeutic efficacy in venous insufficiency and related disorders.
Drugs.
1992;44:1013-1032.
47
Wadworth AN, Faulds D. Hydroxyethylrutosides. A review of its pharmacology, and therapeutic efficacy in venous insufficiency and related disorders.
Drugs.
1992;44:1013-1032.
48
Wright DD, Franks PJ, Blair SD, et al. Oxerutins in the prevention of recurrence in chronic venous ulceration: randomized controlled trial.
Br J Surg (England). 1991;78:1269-1270.
49
Wijayanegara H, Mose JC, Achmad L, et al. A clinical trial of hydroxyethylrutosides in the treatment of hemorrhoids of pregnancy.
J Int Med Res.
1992;20:54-60.
50
Piller NB, Morgan RG, Casley-Smith JR. A double-blind, cross-over trial of O-(beta-hydroxyethyl)-rutosides (benzo-pyrones) in the treatment of lymphoedema of the arms and legs.
Br J Plast Surg.
1988;41:20-27.
51
Taylor HM, Rose KE, Twycross RG. A double-blind clinical trial of hydroxyethylrutosides in obstructive arm lymphoedema.
Phlebologie.
1993;(suppl 1):22-28.
52
Mortimer PS, Badger C, Clarke I, et al. A double-blind, randomized, parallel-group, placebo-controlled trial of O-(beta-Hydroxyethyl)-Rutosides in chronic arm oedema resulting from breast cancer treatment.
Phlebologie.
1995;10:51-55.
53
Piller NB, Morgan RG, Casley-Smith JR. A double-blind, cross-over trial of O-(beta-hydroxyethyl)-rutosides (benzo-pyrones) in the treatment of lymphoedema of the arms and legs.
Br J Plast Surg.
1988;41:20-27.
54
Taylor HM, Rose KE, Twycross RG. A double-blind clinical trial of hydroxyethylrutosides in obstructive arm lymphoedema.
Phlebologie.
1993;(suppl 1):22-28.
55
Mortimer PS, Badger C, Clarke I, et al. A double-blind, randomized, parallel-group, placebo-controlled trial of O-(beta-Hydroxyethyl)-Rutosides in chronic arm oedema resulting from breast cancer treatment.
Phlebologie.
1995;10:51-55.
56
Fassina A, Rubinacci A. Post-traumatic oedemas. A controlled study into the activity of hydroxyethylrutoside [translated from Italian].
Gazz Med Ital Arch Sci.
1987;146:103-109.
57
MacLennan WJ, Wilson J, Rattenhuber V, et al. Hydroxyethylrutosides in elderly patients with chronic venous insufficiency: its efficacy and tolerability.
Gerontology
1994;40:45-52.
58
Wadworth AN, Faulds D. Hydroxyethylrutosides. A review of its pharmacology, and therapeutic efficacy in venous insufficiency and related disorders.
Drugs.
1992;44:1013-1032.
59
Petruzzellis V, Troccoli T, Candiani C, et al. Oxerutins (Venoruton): efficacy in chronic venous insufficiency—a double-blind, randomized, controlled study.
Angiology. 2002;53:257-263.
60
Incandela L, Belcaro G, Renton S, et al. HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides) in venous hypertensive microangiopathy: A prospective, placebo-controlled, randomized trial.
J Cardiovasc Pharmacol Ther. 2002;7(Suppl 1):S7-S10.
61
Incandela L, Cesarone MR, DeSanctis MT, et al. Treatment of diabetic microangiopathy and edema with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): A prospective, placebo-controlled, randomized study.
J Cardiovasc Pharmacol Ther. 2002;7(Suppl 1):S11-S15.